Manufactured Yttrium Barium Copper Nano Oxide for Medicinal Applications

In light of the considerable interest surrounding the antibacterial properties of nanometal oxides and high-temperature superconductors, this study focuses on the synthesis of YBa2Cu3O7 (YBCO) using the Sol-Gel method. The research delves into the experimental aspects of nanoparticle (NP) synthesis...

Full description

Saved in:
Bibliographic Details
Main Authors: Rania Daha, Manel Bouloudenine, Katia Djenadi, Tarek Tahraoui, Stefano Bellucci, Abdelaziz Rabehi
Format: Article
Language:English
Published: Universidade Federal de Viçosa (UFV) 2023-09-01
Series:The Journal of Engineering and Exact Sciences
Subjects:
Online Access:https://periodicos.ufv.br/jcec/article/view/16379
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In light of the considerable interest surrounding the antibacterial properties of nanometal oxides and high-temperature superconductors, this study focuses on the synthesis of YBa2Cu3O7 (YBCO) using the Sol-Gel method. The research delves into the experimental aspects of nanoparticle (NP) synthesis and aims to elucidate the antibacterial potential of YBCO NPs, a high-temperature superconductor, against four distinct bacteria. These bacteria were subjected to varying concentrations of YBCO NPs (0.01 mg/ml, 0.025 mg/ml, 0.05 mg/ml, and 0.1 mg/ml). Comprehensive characterization of the synthesized nanoparticles encompassed techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and thermogravimetric (TG) analysis. Remarkably, the Gram-positive strains, including Staphylococcus epidermidis and Methicillin-resistant Staphylococcus aureus (MRSA), exhibited pronounced susceptibility to the YBCO NPs, while Gram-negative strains displayed minimal response. Intriguingly, even at elevated concentrations of 0.01, 0.025, 0.05, and 0.1 mg/ml, these bacterial strains showcased resilient resistance. This research sheds light on the potential of YBCO NPs as an antibacterial agent against specific pathogens.
ISSN:2527-1075